3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
48
Multiple Myeloma
39
Lymphoma, Large B-Cell, Diffuse
38
Burkitt Lymphoma
34
Lymphoma
31
Leukemia, Myeloid, Acute
31
Lymphoma, Non-Hodgkin
29
Recurrence
27
Breast Neoplasms
27
Neoplasms
23
Lymphoma, B-Cell
23
Myelodysplastic Syndromes
22
Leukemia, Lymphocytic, Chronic, B-Cell
22
Lymphoma, Follicular
20
Hodgkin Disease
18
Triple Negative Breast Neoplasms
17
Melanoma
17
Leukemia
17
Ovarian Neoplasms
16
Hematologic Neoplasms
15
Neuroblastoma
14
Lymphoma, Mantle-Cell
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
12
Pancreatic Neoplasms
12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
12
Leukemia, Biphenotypic, Acute
11
Neoplasm Metastasis
10
Lymphoma, B-Cell, Marginal Zone
10
Leukemia, Myelomonocytic, Chronic
10
Sarcoma
9
Interventions
Pemetrexed
4
Spinal Puncture
3
Radiotherapy
3
aflutinib
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Bevacizumab
2
toripalimab
1
sintilimab
1
pertuzumab
1
lorlatinib
1
azeliragon
1
adavosertib
1
Trastuzumab
1
Referral and Consultation
1
Radiation
1
Physical Examination
1
Immunotherapy, Adoptive
1
Immune Checkpoint Inhibitors
1
GDC-0084
1
Drug Therapy
1
Deferoxamine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Meningeal Carcinomatosis
×
Cyclophosphamide
×
90 days
×
Clear all
No trials found.